The global Medical Non-Inactivated Virus Sampling Tubes market size is predicted to grow from US$ 7.49 million in 2025 to US$ 12.33 million in 2032; it is expected to grow at a CAGR of 7.5% from 2026 to 2032.

In 2025, global sales of Medical Non-Inactivated Virus Sampling Tubes reached approximately 5.3 million units, with an average market price of about USD 1.3 per unit, an annual production capacity of roughly 7.5 million units, and an industry-average gross margin of approximately 26%.

A Medical Non-Inactivated Virus Sampling Tube is a laboratory consumable designed for collecting, transporting, and temporarily preserving live virus specimens (e.g., respiratory, enteric, or bloodborne viruses). These tubes typically consist of a transparent or semi-transparent plastic body, a secure cap, and a preservation medium that maintains viral integrity and infectivity for downstream molecular testing, viral isolation, culture, or research purposes. Key design considerations include leak-proof sealing, operator safety, transport convenience, and clear labeling. They are widely used in clinical diagnostics, public health surveillance, research laboratories, and emergency outbreak testing scenarios.

Upstream components include medical-grade plastics (PP, PS), caps and sealing gaskets, viral preservation medium ingredients (buffers, protein stabilizers, preservatives), and labeling/printing materials. Some manufacturers also require sterilization equipment or external sterilization services (gamma irradiation or ethylene oxide). Production is generally OEM-based, integrating tubes, caps, preservation medium, and labeling into a finished product. End users include hospitals, public health laboratories, third-party testing facilities, and research units. Non-inactivated virus sampling tubes are single-use consumables, discarded after sampling, transport, or testing. Consumption scales with sample volume; large public health labs or outbreak monitoring centers may use thousands to tens of thousands per day. Many laboratories pair these tubes with transport boxes, ice packs, and labeling systems to ensure sample safety and traceability.

United States market for Medical Non-Inactivated Virus Sampling Tubes is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Medical Non-Inactivated Virus Sampling Tubes is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Medical Non-Inactivated Virus Sampling Tubes is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Medical Non-Inactivated Virus Sampling Tubes players cover Wondfo, Vazyme, Shanghai Bojie Medical, Beijing Baicare, Huachenyang, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

Infinity Market Research newest research report, the ?Medical Non-Inactivated Virus Sampling Tubes Industry Forecast? looks at past sales and reviews total world Medical Non-Inactivated Virus Sampling Tubes sales in 2025, providing a comprehensive analysis by region and market sector of projected Medical Non-Inactivated Virus Sampling Tubes sales for 2026 through 2032. With Medical Non-Inactivated Virus Sampling Tubes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Non-Inactivated Virus Sampling Tubes industry.

This Insight Report provides a comprehensive analysis of the global Medical Non-Inactivated Virus Sampling Tubes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Non-Inactivated Virus Sampling Tubes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Medical Non-Inactivated Virus Sampling Tubes market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Non-Inactivated Virus Sampling Tubes and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Non-Inactivated Virus Sampling Tubes.

This report presents a comprehensive overview, market shares, and growth opportunities of Medical Non-Inactivated Virus Sampling Tubes market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    PP
    PS
    Others
    Segmentation by Tube Volume:
    1?3 mL
    3?5 mL
    Above 5 mL

Segmentation by Application:

    Clinical
    Public Health
    Research Grade
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Wondfo
    Vazyme
    Shanghai Bojie Medical
    Beijing Baicare
    Huachenyang
    EKF
    Youkang Biotechnology
    Goldsite Diagnostics
    VanGenes
    MEDICO TECHNOLOGY
    LAKEbio
    Dewei Medical
    YUGOMED

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Non-Inactivated Virus Sampling Tubes market?
What factors are driving Medical Non-Inactivated Virus Sampling Tubes market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Non-Inactivated Virus Sampling Tubes market opportunities vary by end market size?
How does Medical Non-Inactivated Virus Sampling Tubes break out by Type, by Application?